These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37805343)
1. Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer. Hendry S; Mamotte L; Mesbah Ardakani N; Leslie C; Tesfai Y; Grieu-Iacopetta F; Izaac K; Singh S; Ardakani R; Thomas M; Giardina T; Robinson C; Frost F; Amanuel B Pathology; 2023 Dec; 55(7):917-921. PubMed ID: 37805343 [TBL] [Abstract][Full Text] [Related]
2. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy. Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples. Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461 [TBL] [Abstract][Full Text] [Related]
4. Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancer. Centeno C; Serra Mitja P; Avila M; Carcereny E; Muñoz-Mármol AM; Moran T; Castellà E; Sanz-Santos J; García Olivé I; Ramirez Serrano JL; Rosell Gratacos A; Andreo García F Pulmonology; 2022; 28(1):28-33. PubMed ID: 32507497 [TBL] [Abstract][Full Text] [Related]
5. Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma. Ekin Z; Nart D; Savaş P; Veral A Balkan Med J; 2021 Sep; 38(5):287-295. PubMed ID: 34558414 [TBL] [Abstract][Full Text] [Related]
6. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Yarmus L; Akulian J; Gilbert C; Feller-Kopman D; Lee HJ; Zarogoulidis P; Lechtzin N; Ali SZ; Sathiyamoorthy V Ann Am Thorac Soc; 2013 Dec; 10(6):636-43. PubMed ID: 24079724 [TBL] [Abstract][Full Text] [Related]
7. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience. Hardy J; Bhatt N; Medford ARL Asia Pac J Clin Oncol; 2022 Apr; 18(2):e32-e38. PubMed ID: 33870634 [TBL] [Abstract][Full Text] [Related]
8. Handling and standardization of EBUS needle aspiration in NSCLC patients: The value of the cell block, a monoinstitutional experience. Parente P; Carbonelli C; Biancofiore G; Sukthi A; Di Micco CM; Vairo M; Fuso P; Taurchini M; Graziano P Thorac Cancer; 2022 Sep; 13(17):2480-2488. PubMed ID: 35868633 [TBL] [Abstract][Full Text] [Related]
9. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer. Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608 [TBL] [Abstract][Full Text] [Related]
10. EBUS-FNA cytologic-histologic correlation of PD-L1 immunohistochemistry in non-small cell lung cancer. Jug R; Giovacchini CX; Liu B; Green CL; Clarke JM; Mahmood K; Pavlisko EN J Am Soc Cytopathol; 2020; 9(6):485-493. PubMed ID: 32336671 [TBL] [Abstract][Full Text] [Related]
14. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer. Esterbrook G; Anathhanam S; Plant PK Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886 [TBL] [Abstract][Full Text] [Related]
15. Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP). Salas C; Martín-López J; Martínez-Pozo A; Hernández-Iglesias T; Carcedo D; Ruiz de Alda L; García JF; Rojo F J Clin Pathol; 2022 Mar; 75(3):193-200. PubMed ID: 33722840 [TBL] [Abstract][Full Text] [Related]
16. PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens. Heymann JJ; Bulman WA; Swinarski D; Pagan CA; Crapanzano JP; Haghighi M; Fazlollahi L; Stoopler MB; Sonett JR; Sacher AG; Shu CA; Rizvi NA; Saqi A Cancer Cytopathol; 2017 Dec; 125(12):896-907. PubMed ID: 29024471 [TBL] [Abstract][Full Text] [Related]
17. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer. Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673 [TBL] [Abstract][Full Text] [Related]
18. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer. Perrotta F; Nankivell M; Adizie JB; Maqsood U; Elshafi M; Jafri S; Lerner AD; Woolhouse I; Munavvar M; Evison M; Booton R; Baldwin DR; Janes SM; Kerr KM; Bianco A; Yarmus L; Navani N Chest; 2020 Sep; 158(3):1230-1239. PubMed ID: 32428509 [TBL] [Abstract][Full Text] [Related]
19. Programmed death-ligand 1 testing of lung cancer cytology specimens obtained with bronchoscopy. Stoy SP; Rosen L; Mueller J; Murgu S Cancer Cytopathol; 2018 Feb; 126(2):122-128. PubMed ID: 29053224 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens. Sakata KK; Midthun DE; Mullon JJ; Kern RM; Nelson DR; Edell ES; Schiavo DN; Jett JR; Aubry MC Chest; 2018 Oct; 154(4):827-837. PubMed ID: 30059678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]